NCT02170935View on ClinicalTrials.gov

Pharmacokinetic (PK) Assessment of BIBR 1048 in Patients After Primary Elective Total Hip Replacement Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

April 30, 2002

Primary Completion Date

June 30, 2002

Conditions
Venous Thromboembolism
Interventions
DRUG

BIBR 1048 capsule

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY